Search alternatives:
significant non » significant gap (Expand Search), significant amount (Expand Search)
sizes decrease » scores decreased (Expand Search), rivers decreased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
Showing 1 - 20 results of 4,491 for search '(( significant non decrease ) OR ( significant ((gap decrease) OR (sizes decrease)) ))', query time: 0.62s Refine Results
  1. 1
    Most significant muscle activation values.

    Most significant muscle activation values. by María Benito-de-Pedro (22057468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Significant repeated measurements sEMG outcomes.

    Significant repeated measurements sEMG outcomes. by María Benito-de-Pedro (22057468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Significant single measurement sEMG outcomes.

    Significant single measurement sEMG outcomes. by María Benito-de-Pedro (22057468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results).

    Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results). by Duc Tran Quang (20564967)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results).

    Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results). by Duc Tran Quang (20564967)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023.

    Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023.

    Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Each subfigure shows a different local size (LS) and context size (CS) configuration, where the reliability of the model across different initializations is measured in R-squared.

    Each subfigure shows a different local size (LS) and context size (CS) configuration, where the reliability of the model across different initializations is measured in R-squared. by Eloy Geenjaar (21533195)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).

    Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  11. 11
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  12. 12
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 13
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 14
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 15
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 16
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 17
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 18
    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.

    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Anthropometric characteristics of smokers and non-smokers.

    Anthropometric characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.

    Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: